Synthesis and antimalarial activity in vitro and in vivo of a new ferrocene-chloroquine analogue

Journal of Medicinal Chemistry

Volumn 40, Issue 23, 1997, Pages 3715-3718

  Biot, Christophe ^a   Glorian, Guillaume ^a   Maciejewski, Lucien A ^b   Brocard, Jacques S ^c   Domarle, Olivier ^d   Blampain, Georgette ^a   Millet, Pascal ^b   Georges, Alain J ^c   Lebibi, Jacques ^d  

^a UNIV LILLE   (France)

^b CENTRE INTERNATIONAL DE RECHERCHES MÉDICALES DE FRANCEVILLE   (Gabon)

^c INSERM   (France)

^d Univ des sci tech de Masuku   (Gabon)

Author keywords

[No Author keywords available]

Indexed keywords

7 CHLORO 4 [[[2 (N,N DIMETHYLAMINO)METHYL]FERROCENYL]METHYL]AMINO]QUINOLINE; AMINOQUINOLINE DERIVATIVE; ANTIMALARIAL AGENT; CHLOROQUINE; FERROCENE DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIMALARIAL ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG RESISTANCE; DRUG SYNTHESIS; FEMALE; MALARIA; MOUSE; NONHUMAN; PLASMODIUM BERGHEI; PLASMODIUM FALCIPARUM; PLASMODIUM YOELII; SUBCUTANEOUS DRUG ADMINISTRATION;

ANIMALS; ANTIMALARIALS; CHLOROQUINE; FEMALE; FERROUS COMPOUNDS; MALARIA; MICE; PLASMODIUM BERGHEI; PLASMODIUM FALCIPARUM; PLASMODIUM YOELII;

EID: 9844247985     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm970401y     Document Type: Article

References (24)

1. (a) WHO. Weekly Epidemiol. Rep. 1996, 3, 17-24.
2. (b) WHO. Weekly Epidemiol. Rep. 1996, 4, 25-32.
3. WHO. Weekly Epidemiol. Rep. 1996, 5, 37-39.
4. Ridley, R. G.; Hofheinz, W.; Matile, H.; Jaquet, C.; Dorn, A.; Masciadri, R.; Jolidon, S.; Richter, W. F.; Guenzi, A.; Girometta, M. A.; Unvyler, H.; Huber, W.; Thaitong, S.; Peters, W. 4-Arninoquinoline Analogues of Chloroquine with Shortened Side Chains Retain Activity Against Chloroquine-resistant Plasmadium falciparum. Antimicrob. Agents Chemother. 1996, 40, 1846-1854.
5. More recently: (a) Jaouen, G.; Vessieres, A.; Butler, I. Bioorganometallic Chemistry: A Future Direction for Transition Metal Organometallic Chemistry? Ace. Chem. Res. 1993,26, 361-369.
6. (b) Jaouen, G.; Vessieres, A.; Butler, I. Chem. and Eng. 1995, 32-36.
7. Vessieres, A.; Vaillant, C.; Gruselle, M.; Vichard, D.; Jaouen, G. Affinity Labeling of Estradiol by Ferrocenyl Tagging of Estradiol 17a-Position. J. Chem. Soc., Chem. Commun. 1990, 837-839.
8. Köpf-Maier, P.; Köpf, P. Non-Platinum-Group Metal Antitumor Agents: History, Current Status and Perpectives. Chem. Rev. 1987,57, 1137-1152.
9. (a) Brocard, J.; Lebibi, J.; Maciejewski, L. Brevet France 9505532,1995.
10. (b) Brocard, J.; Lebibi, J.; Maciejewski, L. Brevet international PCT/FR 96/00721, 1996.
11. Slocum, D. W.; Rockett, B. W.; Hauser, C. R. Ring Metalation with Butyllithium and Condensation with Electrophilic Compound's. Synthesis of 1,2-Disubstituted Ferrocenes. J. Am. Chem. Soc. 1965, 87, 1241-1246.
12. Wright, M. E. l,l'-Bis(tri-n-butylstannyl)ferrocene: Selective Transmetalation Applied to the Synthesis of New Ferrocenyl Ligands. Organometallics 1990, 9, 853-856.
13. Lindsay, J. K.; Hauser, C. R. Aminomethylation of Ferrocene To Form AT^V-Dimethylaminomethylferrocene and Its Conversion to the Corresponding Alcohol and Aldehyde. J. Org. Chem. 1957, 224, 355.
14. (a)Smith, D. R.; Marenthal, M.; Tipton, J. Reduction of Oximes with Lithium Aluminum Hydride. J. Org. Chem. 1952,217,294.
15. (b) Yoon, N. M.; Brown, H. C. Selective Reductions. XII Explorations in Some Representative Applications of Aluminum Hydride for Selective Reductions. J. Am. Chem. Soc. 1968, 90, 2927-2938.
16. Gamage, S. A.; Tepsiri, N.; Wilairat, P.; Wojcik, S. J.; Figgit, D. P.; Ralph, R. K.; Denny, W. A. Synthesis and in Vitro Evaluation of 9-Anilino-3,6-diaminoacridines Active against a Multiresistant Strain of the Malaria Parasite Plasmodium falciparum. J. Med. Chem. 1994, 37, 1486-1494.
17. Basco, L. K.; Ruggeri, C.; Le Bras, J. Molécules Antipaludiques Mécanismes d'Action Mécanismes de Résistance Relation Structure Activitédes Schîzontocîdes Sanguins; Masson: Paris, 1993; pp 147-148.
18. (a) Slater, A. F. G. Cloroquine Mechanism of Drug Action and Resistance in Plasmodium falciparum. Pharmacol. Ther. 1993, 57, 203-235.
19. (b) Borst, P.; Ouelette, M. New Mechanisms of Drug Resistance in Parasitic Protozoa. Annu. Rev. Microbiol. 1995, 49, 427-460.
20. Cowman, A. F. Mechanisms of Drug ' Resistance in Malaria. Aust. N. Z. J. Med. 1995, 25, 837-844.
21. Trager, W.; Jensen, J. B. Human Malarial Parasites in Continuous Culture. Science 1976,193, 673-675.
22. Domarie, O.; Ntoumi, F.; Belleoud, D.; Sail, A.; Georges, A. J.; Millet, P. In Vitro Adaptation of Pasmodium falciparum Isolates from Symptomatic Gabonese Individuals: Polymerase Chain Reaction Typing and Evaluation of Chloroquine Susceptibility. Trans. R. Soc. Trop. Med. Hyg., in press
23. Desjardin, R. E.; Canfield, C. J.; Haynes, J. D.; Chulay, J. D. Quantitative Assessment of Antimalarial Activity in Vitro by a Semiautomated Microdilution Technique. Antimicrob. Agents Chemother. 1979, 16, 710-718.
24. Desjardins, R. E. In Vitro Techniques for Antimalarial Development and Evaluation. In Antimalarial Drugs: Biological Background, Experimental Methods and Drug Resistance; Peters, W., Richards, W. H. G., Eds.; Springer Verlag: Berlin, Heidelberg, New York, Tokyo; pp 179-205.